- Aclaris Therapeutics (NASDAQ:ACRS): Q1 EPS of -$0.65 misses by $0.17.
- Cash, cash equivalents and investments of $85.25M.
- Press Release
Aclaris Therapeutics misses by $0.17
Recommended For You
More Trending News
About ACRS Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| ACRS | - | - |
| Aclaris Therapeutics, Inc. | ||